A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)
Clinical trial NCT01889069 · COMPLETED
Trial details
- NCT number
- NCT01889069
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-31
- Primary completion
- 2019-05-28
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.